journal article·2023-08Open access

CO2-Responsive drug delivery system created by supramolecular design and assembly for safer, more effective cancer therapy

Vo Thuy Thien Ngan, Fasih Bintang Ilhami, Sin-Yu Huang, Ting-Hsuan Su, Hsin-Hsuan Tsai, Chih-Chia Cheng

Abstract

We developed a carbon dioxide (CO2)-responsive supramolecular drug carrier system through a combination of hydrophobic CO2-sensitive imidazole-containing rhodamine 6G (I–R6G) as an efficient anticancer agent and hydrophilic ureido-cytosine (UrCy) end-capped polyethylene glycol (UrCy-PEG) as a self-assembled nanocarrier that could potentially enhance the safety and efficiency of cancer treatment. Owing to the self-complementary quadruple hydrogen bonding interactions between the UrCy moieties at the polymer chain ends, UrCy-PEG can spontaneously self-assemble into spherical-like nanoobjects in water that can effectively encapsulate hydrophobic I–R6G and form co-assembled nanoparticles with tunable sizes (depending on the I–R6G loading content). These nanoparticles display several notable physical features, including high structural stability in normal physiological aqueous media or red blood cell-containing media, unique CO2-responsiveness, and controlled CO2-sensitive I–R6G release. In vitro cytotoxicity assays clearly indicated I–R6G-loaded nanoparticles exerted selective cytotoxicity towards cancer cells, but had no adverse effects on normal cells. I–R6G-loaded nanoparticles exerted significantly higher levels of cytotoxicity at lower doses in CO2-treated cell culture media compared to I–R6G-loaded nanoparticles in pristine media. More importantly, cellular assays demonstrated that—in comparison to I–R6G-loaded nanoparticles in pristine media—CO2-treated culture media accelerated macropinocytic internalization of I–R6G-loaded nanoparticles into cancer cells, and subsequently led to more rapid induction of apoptosis in cancer cells and massive programmed cell death. Thus, this newly created system may act as a potential route to manipulate the drug delivery and release performance of self-assembled nanobjects for efficient cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Supramolecular Chemistry and Complexes · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. Doxil®— the first FDA-approved nano-drug: lessons learned, J Control10.1016/j.jconrel.2012.03.020 ↗
2. Advances in nano-delivery systems for doxorubicin: an updated insight10.1080/1061186X.2017.1380655 ↗
3. US Food and Drug Administration approval overview in metastatic breast cancer10.1200/JCO.2011.39.2613 ↗
4. Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer, Gynecol
5. 5-Fluorouracil: a narrative review on the role of regulatory mechanisms in driving resistance to this chemotherapeutic agent10.3389/fonc.2021.658636 ↗
6. Nano based drug delivery systems: recent developments and future prospects10.1186/s12951-018-0392-8 ↗
7. Pharmaceutical applications of cyclodextrins: basic science and product development10.1111/j.2042-7158.2010.01030.x ↗
8. Insoluble drug delivery strategies: review of recent advances and business prospects10.1016/j.apsb.2015.07.003 ↗
9. Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers10.1016/j.jconrel.2011.11.031 ↗
10. Salt formation to improve drug solubility10.1016/j.addr.2007.05.010 ↗
11. Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities10.1016/j.ejps.2006.10.008 ↗
12. Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers, Bioorg10.1016/j.bmcl.2014.10.088 ↗
13. A CO2-responsive imidazole-functionalized fluorescent material mediates cancer chemotherapy10.3390/pharmaceutics15020354 ↗
14. pH sensing and regulation in cancer10.3389/fphys.2013.00370 ↗
15. The acidic tumor microenvironment: a target for smart cancer nano-theranostics10.1093/nsr/nwx062 ↗
16. Hypercapnia suppresses the HIF-dependent adaptive response to hypoxia10.1074/jbc.M116.713941 ↗
17. Influence of the hypercapnic tumor microenvironment on the viability of Hela cells screened by a CO2-gradient-generating device10.1021/acsomega.1c04422 ↗
18. Integrating stimuli-responsive properties in host-guest supramolecular drug delivery systems10.7150/thno.31913 ↗
19. Stimuli-responsive drug-delivery systems based on supramolecular nanovalves10.1016/j.matt.2019.05.019 ↗
20. Supramolecular engineering of hydrogels for drug delivery10.1016/j.addr.2021.02.002 ↗
21. Advances in multiple stimuli-responsive drug-delivery systems for cancer therapy10.2147/IJN.S293427 ↗
22. Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting10.3390/cancers13040670 ↗
23. Supramolecular biomaterials10.1038/nmat4474 ↗
24. Supramolecular cancer nanotheranostics10.1039/D0CS00011F ↗
25. Dynamic supramolecular self-assembly: hydrogen bonding-induced contraction and extension of functional polymers10.1039/C7PY00684E ↗
26. Functionalized graphene nanomaterials: new insight into direct exfoliation of graphite with supramolecular polymers10.1039/C5NR07076G ↗
27. Incorporation of supramolecular polymer-functionalized graphene: towards the development of bio-based high electrically conductive polymeric nanocomposites10.1016/j.compscitech.2017.05.024 ↗
28. Hydrogen bond strength-mediated self-assembly of supramolecular nanogels for selective and effective cancer treatment10.1021/acs.biomac.1c01022 ↗
29. Self-assembled supramolecular nanogels as a safe and effective drug delivery vector for cancer therapy10.1002/mabi.201600370 ↗
30. Size and surface charge characterization of nanoparticles with a salt gradient10.1038/s41467-020-15889-3 ↗
31. A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions10.1007/s11051-008-9435-7 ↗
32. Synthesis and energy-transfer properties of fluorescence sensing bichromophoric system based on rhodamine 6G and 1,8-naphthalimide10.1016/j.snb.2009.09.012 ↗
33. Imaging of intracellular acidic compartments with a sensitive rhodamine based fluorogenic pH sensor10.1039/c1an15108h ↗
34. A H-bond strategy to develop acid-resistantphotoswitchable rhodamine spirolactams forsuper-resolution single-molecule localizationmicroscopy10.1039/C9SC01284B ↗
35. Syntheses, properties, and applications of CO2-based functional polymers
36. Construction of an environmentally friendly octenylsuccinic anhydride modified pH-sensitive chitosan nanoparticle drug delivery system to alleviate inflammation and oxidative stress10.1016/j.carbpol.2020.115972 ↗
37. Hemolysis tendency of anticancer nanoparticles changes with type of blood group antigen: an insight into blood nanoparticle interactions10.1016/j.msec.2020.110645 ↗
38. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles10.1016/j.biomaterials.2010.01.065 ↗
39. Overcoming negatively charged tissue barriers: drug delivery using cationic peptides and proteins10.1016/j.nantod.2020.100898 ↗
40. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance10.3389/fmolb.2020.00193 ↗
41. Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy10.1016/j.biomaterials.2020.120557 ↗
42. Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells10.1002/mabi.200800123 ↗
43. Insight into cellular uptake and intracellular trafficking of nanoparticles10.1186/s11671-018-2728-6 ↗
44. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R ↗
45. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V10.1016/0022-1759(95)00072-I ↗
46. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles10.2147/IJN.S36111 ↗